Skip to content

13F-HR/A filed by STEMPOINT CAPITAL LP

STEMPOINT CAPITAL LP filed this 13F-HR/A for the quarter ended 2024-06-30, filed 2024-08-13, with 43 holding rows worth $340,279,233.

Accession
0001420506-24-001418
Filed
2024-08-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, amendment of type restatement, 44 entries on the cover page, a total value of $340,279,233 stated on the cover page (in dollars after the unit check, H1), rows summing to $340,279,233 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SYNDAX PHARMACEUTICALS INC87164F105COM1,412,176$28,991,973dollars as filed
ROIVANT SCIENCES LTDG76279101SHS2,712,741$28,673,672dollars as filed
IMMUNOVANT INC45258J102COM1,011,879$26,713,606dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock551,095$24,683,545dollars as filed
MERUS N VN5749R100COM288,668$17,080,486dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock280,709$15,492,330dollars as filed
AMICUS THERAPEUTICS INC03152W109COM1,495,047$14,830,866dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR339,351$11,500,605dollars as filed
Applied Therapeutics Inc03828A101Common Stock2,211,320$10,326,864dollars as filed
Merck & Co.,Inc.58933Y105COM81,508$10,153,452dollars as filed
GSK PLC SPONSORED ADR37733W204ADR245,933$9,468,421dollars as filed
AUTOLUS THERAPEUTICS PLC SPON05280R100COM2,662,732$9,266,307dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM965,392$8,978,146dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,178,105$8,812,225dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM736,765$8,679,092dollars as filed
BIOHAVEN LTDG1110E107COM233,255$8,096,281dollars as filed
VISTAGEN THERAPEUTICS INC92840H400COM1,848,582$5,848,164dollars as filed
IMMATICS N.VN44445109SHS502,207$5,835,645dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock251,010$5,828,452dollars as filed
INSMED INC COM PAR $.01457669307Stock86,980$5,827,660dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW144,467$5,346,724dollars as filed
LARIMAR THERAPEUTICS INC517125100COM704,349$5,106,530dollars as filed
Tscan Therapeutics Inc89854M101COM845,069$4,943,654dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM271,057$4,881,737dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW101,479$4,591,925dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK696,464$4,318,077dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK203,273$4,242,308dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock1,202,675$3,980,854dollars as filed
JANUX THERAPEUTICS INC47103J105COM92,949$3,893,634dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock101,787$3,573,742dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW150,450$3,537,080dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK343,810$3,427,786dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW143,775$3,263,693dollars as filed
BLACK DIAMOND THERAPEUTICS I09203E105COM674,198$3,141,763dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM744,412$2,977,648dollars as filed
NEUROGENE INC64135M105COMMON STOCK78,601$2,860,290dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS124,866$2,372,454dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK984,113$2,046,955dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS200,000$2,044,000dollars as filed
SURROZEN INC86889P208COMMON STOCK143,510$1,571,435dollars as filed
PERCEPTIVE CAPITAL SOLUTIONSG70077105CL A ORD SHS150,000$1,509,000dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW29,259$1,210,152dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM500,000$350,000dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-24-001376 superseded2024-08-13acceptance time not in the bulk data set
13F-HR/A 0001420506-24-001418this filing2024-08-13acceptance time not in the bulk data set